https://oiger.de/2025/11/03/sachsen-und-flamen-vertiefen-innovationspartnerschaft/195624
#Sachsen #Flandern. Kooperation #Technologie #Innovation #Mikroelektronik #Wasserstoffwirtschaft #Radiopharmazie #Imec #Leuven #Radiopharmacy #Cluster
Postdoctoral Fellow (Nanomedicine and Bioimaging)
Purdue University
See the full job description on jobRxiv: https://jobrxiv.org/job/purdue-university-27778-postdoc-fellow-in-nanomedicine-and-molecular-imaging/
#Molecularimaging #nanomaterials #nanomedicine #radiopharmacy #TherapeuticNanotechnologyandPrecisionMedicine #ScienceJobs #hiring #research
https://jobrxiv.org/job/purdue-university-27778-postdoc-fellow-in-nanomedicine-and-molecular-imaging/?fsp_sid=3770
Postdoctoral Fellow (Nanomedicine and Bioimaging)
Purdue University
See the full job description on jobRxiv: https://jobrxiv.org/job/purdue-university-27778-postdoc-fellow-in-nanomedicine-and-molecular-imaging/
#Molecularimaging #nanomaterials #nanomedicine #radiopharmacy #TherapeuticNanotechnologyandPrecisionMedicine #ScienceJobs #hiring #research
https://jobrxiv.org/job/purdue-university-27778-postdoc-fellow-in-nanomedicine-and-molecular-imaging/?fsp_sid=2608
From fundamental research to medical applications 🚀 A team of researchers from the Helmholtz Institute Mainz – a branch of GSI/FAIR – and @unimainz has secured funding for their spin-off project AVLIS: Atomic Vapor Laser Isotope Separation.
Dr. Dominik Studer, Dr. Tom Kieck, and Yuki Ishikawa receive €230,000 through the @helmholtz Enterprise spin-off program to prepare the foundation of a #startup – with promising applications in #radiopharmacy and fundamental research https://www.gsi.de/en/start/news/details/2025/08/21/avlis
A team of scientists from the Helmholtz Institute Mainz, a branch of GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt and Johannes Gutenberg University Mainz, has secured funding under the Helmholtz Enterprise spin-off program. Dr. Dominik Studer, Dr. Tom Kieck, and their colleague Yuki Ishikawa received €230,000 in funding over 14 months for their spin-off project AVLIS (Atomic Vapor Laser Isotope Separation) with the aim to prepare for the establishment of a company. The developed ...
Our university, the university hospital, and ITM #Isotope Technologies Munich SE sign a research frame agreement aimed at providing more targeted therapies for #cancerpatients: http://go.tum.de/406128
#radiopharmacy #nuclearmedicine
📷ITM Isotope Technologies
Thanks to the radiation they emit, radioactive compounds are suited both to imaging and treating cancers. By appropriately combining them in novel, so-called radionuclide theranostics, both applications can be dovetailed. A radiopharmacy team at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and Heidelberg University has now presented such a system in the Journal of the American Chemical Society (DOI: 10.1021/jacs.2c08438) that successfully solves one of the biggest problems to date: it works at physiologically relevant temperatures.